Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#221 of 458

Brandon Folkes

HC Wainwright & Co. · Equity Research Analyst
ProvisionalRating since 2025No new ratings since Sep 2025

Analyst rating accuracy & track record

Brandon Folkes is an equity research analyst at HC Wainwright & Co.. Quantellect has scored 27 of their stock calls across 19 companies. Their picks beat their sector 42% of the time over the next 12 months, and their price targets were reached 30% of the time within a year.

Win % vs sector
42%
PT Hit % (12mo)
30%
Avg sector-excess
−5.1%
Scored calls
27
Tickers
19
Tier
Provisional

Track record

Quantellect has scored 27 of Brandon Folkes's stock calls across 19 companies, dating back to 2025. Their rated stocks beat their own sector 42% of the time over the next 12 months. On a typical call, a Folkes pick returned −5.1% more than its sector over the following year.

Of the scored calls, 27 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
MNKDMannKind Corp
Buy$11.00Sep 2025−54.6%Miss
DERMJourney Medical Corp
Buy$13.00Aug 2025−28.1%Miss
VALNValneva SE ADR
Buy$18.00Aug 2025−53.9%Miss
ACHVAchieve Life Sciences Inc
Buy$12.00Aug 2025+145.6%Miss
EPRXEupraxia Pharmaceuticals Inc. Common Stock
Buy$12.00Aug 2025+8.9%Miss
VALNValneva SE ADR
Buy$18.00Aug 2025−69.9%Miss
CNTBConnect Biopharma Holdings Ltd
Buy$7.00Aug 2025−9.2%Miss
PYPDPolyPid
Buy$13.00Aug 2025+12.0%Miss
XERSXeris Pharmaceuticals Inc
Buy$10.00Aug 2025−11.4%Hit
COLLCollegium Pharmaceutical Inc
Buy$44.00Aug 2025−61.1%Hit
CRMDCorMedix Inc
Buy$17.00Aug 2025−56.2%Miss
ANIPANI Pharmaceuticals Inc
Buy$93.00Aug 2025−41.7%Hit
SGMTSagimet Biosciences Inc. Series A Common Stock
Buy$29.00Aug 2025−25.2%Miss
INDVIndivior PLC Ordinary Shares
Buy$28.00Aug 2025+46.2%Hit
ENTAEnanta Pharmaceuticals Inc
Buy$20.00Jul 2025+29.6%Miss
MNKDMannKind Corp
Buy$9.00Jul 2025−19.9%Miss
ANIPANI Pharmaceuticals Inc
Buy$84.00Jul 2025+5.8%Hit
ZVRAZevra Therapeutics Inc.
Buy$26.00Jul 2025+21.1%Miss
CRMDCorMedix Inc
Buy$20.00Jun 2025−51.0%Miss
EPRXEupraxia Pharmaceuticals Inc. Common Stock
Buy$12.00Jun 2025+5.0%Miss
CNTBConnect Biopharma Holdings Ltd
Buy$7.00Jun 2025+108.2%Miss
HRTXHeron Therapeuti
Buy$6.00Jun 2025−96.9%Miss
PYPDPolyPid
Buy$13.00Jun 2025+14.6%Miss
MISTMilestone Pharmaceuticals Inc
Buy$5.00Jun 2025−44.8%Miss
PYPDPolyPid
Buy$11.00Jun 2025+42.8%Miss
CRDLCardiol Therapeutics Inc Class A
Buy$9.00Jun 2025−24.2%Miss
TRVITrevi Therapeutics Inc
Buy$21.00May 2025+111.2%Miss
Prev1
Go to

Brandon Folkes: analyst track record FAQ

Is Brandon Folkes a good stock analyst?

Yes, by track record. Brandon Folkes ranks number 221 of 458 of the analysts Quantellect scores, with a Q Score of 35 out of 100. Past results do not guarantee future ones.

What is Brandon Folkes's win rate?

Brandon Folkes's win rate is 42%. Across 27 scored calls, their rated stocks beat their sector 42% of the time over the next 12 months. On a typical call they returned −5.1% more than the sector.

What stocks and sectors does Brandon Folkes cover?

Brandon Folkes covers 19 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Brandon Folkes's price targets accurate?

Brandon Folkes's price targets are reached within 12 months 30% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Brandon Folkes's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Brandon Folkes rank among Wall Street analysts?

Brandon Folkes ranks number 221 of 458 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.